NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 312 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,559 | +4.1% | 60 | -4.8% | 0.00% | – |
| Q2 2022 | $4,379 | -37.1% | 63 | -25.0% | 0.00% | – |
| Q1 2022 | $6,959 | +15.9% | 84 | +5.0% | 0.00% | – |
| Q4 2021 | $6,006 | -72.8% | 80 | -57.9% | 0.00% | -100.0% |
| Q3 2021 | $22,072 | -45.6% | 190 | +3.8% | 0.00% | -50.0% |
| Q2 2021 | $40,593 | +207.1% | 183 | +83.0% | 0.00% | +100.0% |
| Q1 2021 | $13,218 | -23.6% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $17,304 | +210.9% | 100 | +100.0% | 0.00% | – |
| Q3 2020 | $5,566 | -92.2% | 50 | -95.9% | 0.00% | -100.0% |
| Q2 2020 | $71,634 | +431.9% | 1,208 | +504.0% | 0.01% | +400.0% |
| Q1 2020 | $13,468 | +59.8% | 200 | +100.0% | 0.00% | 0.0% |
| Q4 2019 | $8,427 | -82.1% | 100 | -84.1% | 0.00% | -75.0% |
| Q3 2019 | $47,111 | – | 630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |